[1]              Jordan CT. 2004. Cancer stem cell biology: from leukemia to solid tumors. Current Opinion in Cell Biology, 16（6）:708-712. 文献编号: 16001.

      [2]              Donaldson TD, Duronio RJ. 2004. Cancer cell biology: myc wins the competition. Current Biology, 14（11）: R425-R427. 文献编号: 16002.

      [3]              Pontén J. 2001. Cell biology of precancer. European Journal of Cancer, 37（8）：97-113. 文献编号: 16003.

      [4]              Mizejewski GJ. 2001. Alpha-fetoprotein structure and function: relevance to isoforms, epitopes, and conformational variants. Experimental Biology and Medicine, 226: 377-408. 文献编号: 16004.

      [5]              Lamb J, Ramaswamy S, Ford HL, et al. 2003. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell, 114:323–334. 文献编号: 16005.

      [6]              Livingston DM. 2001. Cancer: chromosome defects in the colon. Nature, 410:536-537. 文献编号: 16006.

      [7]              Zech NH. 2004. Adult Stem Cell Manipulation and Possible Clinical Perspectives. Journal für Reproduktionsmedizin und Endokrinologie, 1 (2):91-99. 文献编号: 16007.

      [8]              Santini MT, Rainaldi G, Indovina PL. 2000. Apoptosis, cell adhesion and the extracellular matrix in the three-dimensional growth of multicellular tumor spheroids. , 36:75–87. 文献编号: 16008.

      [9]              Alberts B, Johnson A, Lewis J, et al. 2002. Cancer, in: Molecular Biology of the Cell 4th ed. Garland Science, 1313-1362. 文献编号: 16009.

  [10]              Amsterdam A, Selvaraj N. 1997. Control of differentiation, transformation, and apoptosis in granulosa cells by oncogenes, oncoviruses, and tumor suppressor genes. Endocr. Rev, 18: 435. 文献编号: 16010.

  [11]              Harris CC. 1996. Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst, 88: 1442 - 1455. 文献编号: 16011.

  [12]              Oren M. 1999. Regulation of the p53 tumor suppressor protein. J. Biol. Chem, 274: 36031. 文献编号: 16012.

  [13]              Ullrich SJ, Anderson CW, Mercer WE, et al. 1992. The p53 tumor suppressor protein, a modulator of cell proliferation. . Biol. Chem, 267: 15259 - 15262. 文献编号: 16013.

  [14]              Tsao AS, Kim ES, Hong WK. 2004. Chemoprevention of cancer. CA Cancer J Clin, 54: 150 - 180. 文献编号: 16014.

  [15]              de Caestecker MP, Piek E, Roberts AB. 2000. Role of transforming growth factor-ß signaling in cancer. J Natl Cancer Inst, 92: 1388 - 1402. 文献编号: 16015.

  [16]              Prokocimer M, Rotter V. 1994. Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages. Blood, 84: 2391 - 2411. 文献编号: 16016.

  [17]              Lund AH, van Lohuizen M. 2004. Epigenetics and cancer. Genes & Dev, 18: 2315 - 2335. 文献编号: 16017.

  [18]              Reshmi SC, Gollin SM. 2005. Chromosomal instability in oral cancer cells. J. Dent. Res, 84: 107 - 117. 文献编号: 16018.

  [19]              Tamura M, Gu JG, Tran H, Yamada KM. 1999. PTEN gene and integrin signaling in cancer. J Natl Cancer Inst, 91: 1820 - 1828. 文献编号: 16019.

  [20]              Pöschl G, Seitz HK. 2004. Alcohol and cancer. Alcohol & Alcoholism, 39: 155 - 165. 文献编号: 16020.

  [21]              Grady WM. 2005. Transforming growth factor-ß, smads, and cancer. Clin. Cancer Res, 11: 3151 - 3154. 文献编号: 16021.

  [22]              Adjei AA. 2001. Blocking oncogenic ras signaling for cancer therapy. J Natl Cancer Inst, 93: 1062 - 1074. 文献编号: 16022.

  [23]              Weinstein IB. 1988. The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment-twenty-seventh g. H. A. CANCER RESEARCH, 48:4135-4143. 文献编号: 16023.

  [24]              Hughes-DaviesL, Huntsman D ,Ruas M, et al. 2003. EMSY links the BRCA2 pathway to Sporadic Breast and Ovarian Cancer. Cell, 115:523–535. 文献编号: 16024.

  [25]              Bishop AJR, Schiestl RH. 2002. Homologous Recombination and Its Role.in Carcinogenesis. Journal of Biomedicine and Biotechnology, 2 (2) :75–85. 文献编号: 16025.

  [26]              Fuessel S, Sickert D, Meye A, et al. 2003. Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCR. International Journal of Oncology, 23: 221-228. 文献编号: 16026.

  [27]              Lin SY，Elledge1 SJ. 2003. Multiple Tumor Suppressor Pathways Negatively Regulate Telomerase. Cell, 113:881–889. 文献编号: 16027.

  [28]              Sturgeon C. 2002. Practice Guidelines for Tumor Marker.Use in the Clinic . Clinical Chemistry, 48(8):1151–1159. 文献编号: 16028.

  [29]              Sherr CJ. 2004. Principles of Tumor Suppression. Cell, 116:235–246. 文献编号: 16029.

  [30]              Irish JM, Hovland R, Krutzik PO, et al. 2004. Single Cell Profiling of Potentiated Phospho-Protein Networks in Cancer Cells. Cell, 118:217–228. 文献编号: 16030.

  [31]              Valk-Lingbeek ME, Bruggeman SWM, van Lohuizen M. 2004. Stem Cells and Cancer: The Polycomb Connection. Cell, 118:409–418. 文献编号: 16031.

  [32]              Reya T, Morrison SJ, Clarke MF, Weissman IL. 2001. Stem cells, cancer, and cancer stem cells. Nature, 414:105-111. 文献编号: 16032.

  [33]              Marx J. 2002. Tackling cancer at the telomeres. Science, 295:2350. 文献编号: 16033.

  [34]              Taipale J, Beachy PA. 2001. The Hedgehog and Wnt signalling pathways in cancer. Nature, 411:349-354. 文献编号: 16034.

  [35]              Al-Hajj M, Becker1 MW, Wicha M, et al. 2004. Therapeutic implications of cancer stem cells. Current Opinion in Genetics & Development, 14:43–47. 文献编号: 16035.

  [36]              Novaković S. 2004. Tumor markers in clinical oncology. Radiol Oncol, 38(2): 73-83. 文献编号: 16036.

  [37]              Kopper L, Hajdú M. 2004. Tumor Stem Cells. Pathology Oncology Research, 10(2):69-73. 文献编号: 16037.

  [38]              Iijima M, Devreotes P. 2002. Tumor Suppressor PTEN Mediates Sensing of Chemoattractant Gradients. Cell, 109:599–610. 文献编号: 16038.

  [39]              Kanda T, Wahl GM. 2000. The Dynamics of Acentric Chromosomes in Cancer Cells Revealed by GFP-Based Chromosome Labeling Strategies. Journal of Cellular Biochemistry Supplement, 35:107-114. 文献编号: 16039.